Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thank you Nixynoo, you did an outstanding job of live reporting.
Great effort glad Chrishar gave you a heads up that was invaluable I failed five times to get in .
Hi Wilson - no I don't sadly, otherwise my posts wouldn't be littered with typos!
France on the way back up now. I think this will be one of those continual rises over the next few weeks as it sinks in and numis do their broker note.
Pretty phenomenal really when you consider that the projected FY results of 150mE having even been updated to take into account the contract with the DoH from this morning worth 250mE in the next 6 months .... at a conservative 200mE FY the PE is ridiculously low
Tks for the updates everyone nixynoo do you transcribe for a living incredible.
Firstly thanks to the NCYT Live team! So after an uplifting AGM wtf is happening to the Sp. no fear for the future.
GM (last words): I must stress that we are only at the beginning of this journey (not exact quote)
Transformation of the company not over yet! :)
Just saw that Sheerclass.... very odd.... profit taking? They just finished on I must add that we are at the beginning, not the end of this story...
Questions
Can you explain the current and future capacity?
Has room for the significant order pipeline which includes the one received this morning.
This contract was negotiation over a significant period.
New products?
Continue to innovate and build on COVID 19 testing and respiratory and transplant diagnostics.
Progress in France?
2 gene test available, reimbursable.
Next diagnostic area?
Goal to be market leader in respiratory and transplant diagnostics.
Competition, NCYT USP and risks?
$25-40billion revenue available for COVID-19 testing next year. Room for everyone.
Biggest risk is developing infrastructure quickly enough to meet the growing company. Want to create value for shareholders.
Update on US Sales?
USA is one of NCYT top performing countries for sales. Want to strengthen presence, currently one employee. Increase through M and A.
Thinking behind numis?
Work alongside other brokers and help raise profile and broaden shareholder base. Odo to help raise profile in french market.
So, summary, Nothing we didn’t already know. Feels like an hour wasted watching on the ****tiest connection ever
Euronext suspensed after dropping to €5.78? Mention on Twitter of the French ordering 1000 Q16 /32’s?! What’s going on?
The end of the meeting is to go through the resolutions... Lots of resolutions with regard to buying back shares and share option scheme etc... will see if they all pass
General observation:
So this is what actual professionals look and sound like is it? ... my god these guys are good! :D
Can't believe this is an AIM company!
reimbursable but no contract yet
on the back of the contract received this morning they will be making. more investment in their infrastructure...
Appointed new brokers to raise profile inked markets .... sorry sound terrible towards the end so missed a lot of items!
New broker to broaden exposure to institutional shareholders
Competition ?
Total market for diag is $70Bn this excludes Covid-19 market
Believe there is room for everyone
Short term risk is to deliver our infrastructure fast enough
significant growth potential in the US - looking to grow presence I the US market - only have 1 employee at the moment. Looking to acquire a company / merge to increase this presence
looking to strengthen presence in US recognise the market is "huge"
ST risk is that they don't grow fast enough to meet demand. They are currently ahead of the curve on this and keeping up
25-40bn to be spent worldwide on testing for covid
GM - confirmed they have 2-gene test in stock ready to go and also confirm French reimbursement approval
Blimey - they have really kept their powder dry with no capacity or supply constraints within context of covid and again growing new product